1. Home
  2. KTTA vs SPCB Comparison

KTTA vs SPCB Comparison

Compare KTTA & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • SPCB
  • Stock Information
  • Founded
  • KTTA 2020
  • SPCB 1988
  • Country
  • KTTA United States
  • SPCB Israel
  • Employees
  • KTTA N/A
  • SPCB N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • KTTA Health Care
  • SPCB Technology
  • Exchange
  • KTTA Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • KTTA 4.5M
  • SPCB 5.6M
  • IPO Year
  • KTTA 2021
  • SPCB N/A
  • Fundamental
  • Price
  • KTTA $4.19
  • SPCB $2.88
  • Analyst Decision
  • KTTA
  • SPCB
  • Analyst Count
  • KTTA 0
  • SPCB 0
  • Target Price
  • KTTA N/A
  • SPCB N/A
  • AVG Volume (30 Days)
  • KTTA 13.4K
  • SPCB 387.6K
  • Earning Date
  • KTTA 08-13-2024
  • SPCB 08-15-2024
  • Dividend Yield
  • KTTA N/A
  • SPCB N/A
  • EPS Growth
  • KTTA N/A
  • SPCB N/A
  • EPS
  • KTTA N/A
  • SPCB N/A
  • Revenue
  • KTTA N/A
  • SPCB $26,843,000.00
  • Revenue This Year
  • KTTA N/A
  • SPCB $6.34
  • Revenue Next Year
  • KTTA N/A
  • SPCB $16.25
  • P/E Ratio
  • KTTA N/A
  • SPCB $2.17
  • Revenue Growth
  • KTTA N/A
  • SPCB 5.23
  • 52 Week Low
  • KTTA $4.15
  • SPCB $2.55
  • 52 Week High
  • KTTA $17.40
  • SPCB $22.60
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 37.51
  • SPCB 37.65
  • Support Level
  • KTTA $4.43
  • SPCB $2.55
  • Resistance Level
  • KTTA $4.91
  • SPCB $3.18
  • Average True Range (ATR)
  • KTTA 0.31
  • SPCB 0.34
  • MACD
  • KTTA -0.02
  • SPCB -0.06
  • Stochastic Oscillator
  • KTTA 3.10
  • SPCB 26.40

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

Share on Social Networks: